The global market for Vascular Grafts is estimated at US$3.5 Billion in 2023 and is projected to reach US$5.9 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes.
Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.
The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes.
Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Endovascular Aneurysm Repair (EVAR) Indication segment, which is expected to reach US$2.6 Billion by 2030 with a CAGR of a 7.1%. The Peripheral Vascular Repair Indication segment is also set to grow at 9.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2023, and China, forecasted to grow at an impressive 9.3% CAGR to reach $687.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Vascular Grafts Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vascular Grafts Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Vascular Grafts Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Cardinal Health, Inc., Baxter International, Inc., Terumo Corporation, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 44 Featured):
- Cardinal Health, Inc.
- Baxter International, Inc.
- Terumo Corporation
- Cook Medical, LLC
- Teleflex, Inc.
- LeMaitre Vascular, Inc.
- MicroPort Scientific Corporation
- iVascular S.L.U
- Jotec GmbH
- ParaGen Technologies
- sunnatech scientific corporation
- Vacis
- Cardiovascular Systems, Inc.
- Healionics
- InnAVasc Medical
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardinal Health, Inc.
- Baxter International, Inc.
- Terumo Corporation
- Cook Medical, LLC
- Teleflex, Inc.
- LeMaitre Vascular, Inc.
- MicroPort Scientific Corporation
- iVascular S.L.U
- Jotec GmbH
- ParaGen Technologies
- sunnatech scientific corporation
- Vacis
- Cardiovascular Systems, Inc.
- Healionics
- InnAVasc Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 481 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3.5 Billion |
| Forecasted Market Value ( USD | $ 5.9 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
